$41M sweet spot round size
Most of their 17 investments are in rounds between $2.4M and $78M
2004
广州海博特医药科技有限公司 raised undisclosed on October 13, 2022
Investors: Tigermed
LTZ Therapeutics raised $17M on April 7, 2022
Investors: Qiming Venture Partners and Tigermed
BioInno Bioscience Co., Ltd. raised undisclosed on December 21, 2021
Investors: BridgeOne Capital, Efung Capital and Tigermed
Undisclosed raised undisclosed on November 15, 2021
Investors: Baidu.ventures and Tigermed
Undisclosed raised $45M on September 13, 2021
Investors: 泰福资本 TF Capital, 博远资本 and Tigermed
Undisclosed raised $100M on July 13, 2021
Investors: 深圳前海勤智国际资本管理有限公司, Lengend Star and Tigermed
鸿运华宁(杭州)生物医药有限公司 raised $78M on March 9, 2021
Investors: Cowin Venture Capital and Tigermed
Undisclosed raised $100M on August 31, 2020
Investors: 盈科创新资产管理有限公司, ICBC Asset Management (Global) and Tigermed
Asieris Pharmaceuticals raised $41M on June 28, 2020
Investors: 盈科创新资产管理有限公司, 博远资本 and Tigermed
CANbridge Life Sciences Ltd. raised $98M on February 18, 2020
Investors: Yuanming Capital, General Atlantic, WuXi AppTec, Hudson Bay Capital Management LP, RA Capital Management, L.P. and Tigermed